MIRA INFORM REPORT

 

 

Report Date :

05.05.2012

 

IDENTIFICATION DETAILS

 

Name :

NOVO PHARM FORMULATIONS PRIVATE LIMITED

 

 

Registered Office :

105, Rajmandir Apartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri, Vadodara – 390007, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

20.03.1995

 

 

Com. Reg. No.:

04-025060

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 Million

 

 

CIN No.:

[Company Identification No.]

U24231GJ1995PTC025060

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDN00416D

 

 

PAN No.:

[Permanent Account No.]

AAACN6793Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharma Products.

 

 

No. of Employees :

120 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 4000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kotra

Designation :

Manager

Contact No.:

91-9227189873

Date :

19.04.2012

 

 

LOCATIONS

 

Registered Office :

105, Rajmandir Apartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri, Vadodara – 390007, Gujarat, India

Tel. No.:

91-265-2342034

Mobile No.:

91-9227189873 (Mr. Kotra)

Fax No.:

91-265-2342033

E-Mail :

novopharm.export@gmail.com

ojaspatel@novo-pharm.com

Website :

www.novopharmformulations.com

Location :

Owned

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Ojasbhai Ravjibhai Patel

Designation :

Director

Address :

B/2, Shaktidham Society, Diwalipura, Old Para Road, Vadodara – 390015, Gujarat, India

Date of Birth/Age :

05.11.1968

Date of Appointment :

25.10.1999

DIN No.:

01763528

Other Directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24231GJ1995PTC025060

NOVO PHARM FORMULATIONS PRIVATE LIMITED

Director

25/10/1999

25/10/1999

-

Active

NO

2

U24231GJ2004PTC044846

BRIYOSIS SOFT CAPS PRIVATE LIMITED

Director

1/04/2006

1/04/2006

26/03/2008

Active

NO

3

U55101GJ2009PTC057474

GRAND MAHI CLUB & BANQUETS PRIVATE LIMITED

Director

7/07/2009

7/07/2009

-

Active

NO

4

U24230GJ2010PTC062760

NOVOTEK FORMULATIONS PRIVATE LIMITED

Director

27/10/2010

27/10/2010

-

Active

NO

 

 

Name :

Mr. Rajivbhai Ashabhai Patel

Designation :

Director

Address :

B/2, Shaktidham Society, Diwalipura, Old Para Road, Vadodara – 390015, Gujarat, India

Date of Birth/Age :

28.09.1940

Date of Appointment :

09.04.2007

DIN No.:

03468857

 

 

KEY EXECUTIVES

 

Name :

Mr. Kotra

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Ojas R. Patel

 

10000

Rajivbhai A. Patel

 

40

Total

 

10040

 

Equity Share Break up (Percentage of Total Equity)

As on 30.09.2011

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharma Products.

 

 

Products :

  • Tablets
  • Hydrochloride Tablets
  • Capsule
  • Dry Syrup
  • Liquid

Exports :

 

Products :

Pharma Products

Countries :

African Countries

 

 

Terms :

 

Selling :

L/C/ Cash/ Credit (30 – 60 days)

 

 

Purchasing :

Cash/ Credit (30 – 60 days)

 

GENERAL INFORMATION

 

Customers :

·         Wholesalers

·         Retailers

·         End Users

 

 

No. of Employees :

120 (Approximately)

 

 

Bankers :

·         Axis Bank, Alkapuri Branch

·         The Baroda City Co-Operative Bank Limited, Sanstha-Vasahat, Raopura, Vadodara-390001, Gujarat, India

·         Kotak Mahindra Bank

·         State Bank of India

 

 

Facilities :

Secured Loan

As on 31.03.2011

(Rs. in Millions)

As on 31.03.2010

(Rs. in Millions)

Kotak Mahindra Bank

0.606

0.000

Total

0.606

0.000

 

 

 

Unsecured Loan

As on 31.03.2011

(Rs. in Millions)

As on 31.03.2010

(Rs. in Millions)

ABN Amro Bank

0.216

0.575

Harshaben K Patel

1.187

1.188

Medico Sales Corporation

0.010

0.411

Samir B Patel

0.400

0.000

Vinaybhai Patel

1.187

1.188

Total

3.000

3.362

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Bhutwala Associates

Chartered Accountants

Address :

203/2, Gayatri Chambers, R. C. Dutt Road, Vadodara – 390007, Gujarat, India

PAN.:

AAPPB0489D

 

 

Associates/Subsidiaries :

Novotek Formulations Private Limited

Address: 106, First Floor, Raj Mandir, 62 Alkapuri Society, R.C. Dutt Road, Vadodara-390007, Gujarat, India

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

20000

Equity Shares

Rs.10/- each

Rs.0.200 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10040

Equity Shares

Rs.10/- each

Rs.0.100 Million

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.150

0.150

0.000

3] Reserves & Surplus

0.921

0.838

0.854

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1.171

1.088

0.954

LOAN FUNDS

 

 

 

1] Secured Loans

0.606

0.000

0.000

2] Unsecured Loans

3.000

3.362

2.812

TOTAL BORROWING

3.606

3.362

2.812

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

4.777

4.450

3.766

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1.396

0.398

0.400

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.185

0.184

DEFERREX TAX ASSETS

0.015

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1.831

1.701

2.218

 

Sundry Debtors

4.463

4.545

2.609

 

Cash & Bank Balances

0.647

0.208

0.268

 

Other Current Assets

0.168

0.168

0.168

 

Loans & Advances

2.262

1.926

0.879

Total Current Assets

9.371

8.548

6.142

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

5.935

4.936

2.929

 

Other Current Liabilities

0.314

0.406

(0.060)

 

Provisions

0.153

0.117

0.498

Total Current Liabilities

6.402

5.459

3.367

Net Current Assets

2.969

3.089

2.775

 

 

 

 

MISCELLANEOUS EXPENSES

0.397

0.778

0.407

 

 

 

 

TOTAL

4.777

4.450

3.766

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

17.466

14.754

15.357

 

 

Other Income

0.640

0.005

0.094

 

 

TOTAL                        

18.106

14.759

15.451

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods Sold

14.328

11.814

12.347

 

 

Administrative, Selling and Distribution Expenses

3.651

2.750

2.825

 

 

TOTAL                        

17.979

14.564

15.172

 

 

 

 

 

 

PROFIT BEFORE TAX

0.127

0.195

0.279

 

 

 

 

 

Less

TAX                                                     

0.045

0.060

0.000

 

 

 

 

 

 

PROFIT AFTER TAX

0.082

0.135

0.279

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

0.082

0.135

0.279

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

2.655

0.000

0.000

 

TOTAL EARNINGS

2.655

0.000

0.000

 

 

 

 

 

 

Earnings Per Share (Rs.)

8.17

NA

NA

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

30.000

 

 

 

 

 

Expected Sales (2012-13) : Rs.40.000 Millions

 

The above information has been parted by Mr. Kotra.

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

0.45

0.91

1.81

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

0.73

1.32

1.82

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.18

2.18

4.26

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.11

0.18

0.29

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

8.55

8.10

6.48

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.46

1.56

1.82

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

Yes

10) Designation of contact person

Yes

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

Yes

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

Yes

20) Export / Import details (if applicable)

Yes

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

Note:

The registered address of the company 201, Saakar Building, Near Sardar Patel Wadi, Sanstha Vasahat, Raopura, Vadodara-390001, Gujarat, India has been shifted to the present address w.e.f. 05.05.2011

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U24231GJ1995PTC025060

Name of the company

NOVO PHARM FORMULATIONS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

105 Rajmandir Appartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri, Vadodara-390007,Gujarat, India

Email : ojaspatel@novo-pharm.com

This form is for

Creation of charge

Type of charge

Immovable Property

Particular of charge holder

The Baroda City Co-Operative Bank Limited, Sanstha-Vasahat, Raopura, Vadodara-390001, Gujarat, India

Email : hemant1969@barodacitybank.com

Nature of instrument creating charge

Deposit of Title Deeds

Date of instrument Creating the charge

26.12.2011

Amount secured by the charge

Rs.0.600 Million

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

@ 12% p.a.

 

Terms of Repayment

In EMI of Rs.0.022 Million each

 

Margin

@ 50%

 

Extent and Operation of the charge

First and Exclusive Charge in favour of The Baroda City Co - Operative Bank Limited

 

Others

Term Loan - Rs.0.600 Million

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Regist. District Sub District Vadodara within Raopura Area B Tikka No. 11/2, S.No. 16 paiki admeasu. 676.67 Sq. Mtrs. and S.No. 6/A/2 paiki 764.41 Sq. mtrs. containing 2nd Floor admeasuring 12457 Sq. Fts paiki bearing Unit No. 201 Sakar Complex, Sanstha-Vasahat Office admeasuring 438.50 Sq. Fts.

 

FIXED ASSETS

 

·         Air Conditioner

·         Computer

·         Electronic Equipment

·         Furniture and Fixtures

·         Mobiles

·         Office Building

·         Office Equipments

·         Scooter

·         Car

·         Punch Machines Dies

·         Refrigerator

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.72

UK Pound

1

Rs.86.98

Euro

1

Rs.70.65

 

 

INFORMATION DETAILS

 

Information Gathered by :

JML

 

 

Report Prepared by :

CTI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.